Key Highlights

  • Lichen International (NASDAQ:LICN) tumbled 84.46% to USD 0.0474 on November 10, 2026, on 25.19 million shares and a relative Volume of 211.14, and published coverage identified no catalyst.
  • Microvast Holdings slid 63.72% after third-quarter Revenue dropped 62.8% to USD 45.8 million, the net loss reached USD 76.8 million and the company release retained its Going Concern warning.
  • iHeartMedia slumped 61.58% after guiding fourth-quarter adjusted EBITDA to USD 135 million to USD 185 million, against total Debt of USD 5,024.3 million and a calculated Equity value near USD 105.3 million.
  • Karyopharm Therapeutics lost 34.75% to USD 0.0261 while in Chapter 11, and YYForce lost 29.83% to USD 0.0668, so all five names finished under USD 1.00.

Lichen International (NASDAQ:LICN): Down 84.46% With No Catalyst Identified

Lichen International (NASDAQ:LICN), a Hong Kong based commercial services firm once named Lichen China, finished at USD 0.0474, a fall of 84.46% from a calculated prior close of USD 0.3050 on Monday, November 9, 2026. Two searches of published coverage found no catalyst, so the decline can be described only through price and volume. Trading of 25.19 million shares at a relative volume of 211.14 implies a normal day near 119,300 shares and roughly USD 1.19 million of turnover (calculated). As general context, slides like this in sub-dollar names often follow discounted equity offerings, convertible note conversions or the fading of a promotional spike, and none is confirmed here. The snapshot Market Value of USD 4.98 million implies about 105.1 million shares (calculated), yet an August statistics page listed 16.44 million shares, a conflict left unresolved. Trailing EPS of USD -1.48 improved by 96.86%, but no P/E exists. A few trades can move this nano-cap, and the drop says nothing about later sessions.

Microvast Holdings (NASDAQ:MVST): Down 63.72% on Q3 Results and Going Concern Wording

Microvast Holdings (NASDAQ:MVST), a battery maker, finished at USD 0.2240, a fall of 63.72% from a calculated prior close of USD 0.6174, after third-quarter results came out on November 9. Revenue dropped 62.8% to USD 45.8 million from USD 123.3 million, the net loss widened to USD 76.8 million from USD 1.5 million, and gross Margin sank to 5.2% from 37.6% following a USD 9.3 million inventory write-down. The release offered no numerical guidance and stated that substantial doubt about going concern has not been alleviated. As general context, a warning like that can make lenders and customers wary. Trading was 16.14 million shares at a relative volume of 4.01, roughly USD 3.62 million (calculated). On 384.5 million shares, calculated market value dropped to about USD 86.1 million, so total debt of USD 177.0 million is roughly 2.1 times equity value, and the stale snapshot figure of USD 238.31 million is set aside. Cash and restricted cash were USD 124.4 million. Dilution and more impairments are risks, and the drop implies no recovery.

iHeartMedia (NASDAQ:IHRT): Down 61.58% on Q3 Results and Fourth-Quarter Guidance

iHeartMedia (NASDAQ:IHRT), a radio and digital audio company, finished at USD 0.68, a fall of 61.58% from a calculated prior close of USD 1.77, following third-quarter results on November 9. Revenue grew 3.3% to USD 1,029.8 million, yet adjusted EBITDA slipped 16.7% to USD 170.5 million from USD 204.8 million, and the fourth-quarter adjusted EBITDA guide was USD 135 million to USD 185 million. The release does not link the decline to a single item. As general context, shrinking margins hurt heavily indebted media companies because interest consumes cash flow. Trading was 11.31 million shares at a relative volume of 13.44, roughly USD 7.69 million (calculated). On 154.8 million shares, calculated market value dropped to about USD 105.3 million versus total debt of USD 5,024.3 million, about 48 times equity value, and the snapshot figure of USD 321.01 million does not reconcile, so it is left out. Cash was USD 139.7 million and the stockholders' Deficit was USD 2,015.4 million. Refinancing risk stands out, and a 52-week range could not be confirmed.

Karyopharm Therapeutics (NASDAQ:KPTI): Down 34.75% on Chapter 11 and a Delisting Notice

Karyopharm Therapeutics (NASDAQ:KPTI) finished at USD 0.0261, a fall of 34.75% from a calculated prior close of USD 0.0400, as the company sits in bankruptcy. It and its Subsidiary KPT Texas LLC filed Chapter 11 petitions on November 2, 2026, Nasdaq sent a delisting notice on November 4, and an 8-K signed November 5 says trading halts at the open on November 11, 2026, with common and Series A preferred holders due no distribution. This is a process catalyst, not a fresh Tuesday announcement. As general context, forced selling by funds barred from holding Delisted names often weighs on such stocks. Trading was 4.59 million shares at a relative volume of 0.14, roughly USD 0.12 million (calculated). The USD 591.99 thousand market value implies about 22.68 million shares (calculated), and earlier data showed total debt near USD 328.53 million. Trailing EPS was USD -13.08. One tick lower is about 3.8% (calculated), spreads are wide, and the chief risk is a total loss for common holders.

YYForce (NASDAQ:YFOR): Down 29.83% With No Catalyst Identified

YYForce (NASDAQ:YFOR) finished at USD 0.0668, a fall of 29.83% from a prior close of USD 0.0952 that agrees with published price history. Published coverage dated November 9 or 10, 2026 identified no catalyst. The newest company items were a November 3 update citing net Assets near USD 21.9 million and October robotics announcements, among them a 772-room Singapore hotel partnership. The close is about 69% under USD 0.2150 on October 26 (calculated). As general context, nano-caps that ran up on a theme such as humanoid robotics often hand back gains once attention fades or Capital is raised. Trading was 5.89 million shares at a relative volume of 0.88, under the 11.66 million of November 9, roughly USD 0.39 million (calculated). The USD 857.48 thousand market value implies about 12.8 million shares, above the 7.84 million seen in October, which hints at new issuance or a data lag. The USD 20.34 million trailing loss is over 23 times market value (calculated), and a Nasdaq minimum bid notice is possible.

Where Things Stand

The largest sub-dollar loser among market movers on November 10, 2026 was Lichen International (NASDAQ:LICN), down 84.46% with no catalyst identified. Microvast Holdings (NASDAQ:MVST) lost 63.72% on results. iHeartMedia (NASDAQ:IHRT) lost 61.58% on a weaker EBITDA guide. Karyopharm Therapeutics (NASDAQ:KPTI) lost 34.75% in Chapter 11. YYForce (NASDAQ:YFOR) lost 29.83%. The shared feature is a close under USD 1.00 after a steep drop. Large one-day moves in thinly traded names can reverse the next session, and these lists rest on a published screener snapshot of the regular session on November 10, 2026.